We are live on ! Find out more
HRCM

Hood River Capital Management Portfolio holdings

AUM $9.98B
1-Year Est. Return 145.42%
This Fund
S&P 500
This Quarter Est. Return
+17.85%
1 Year Est. Return
+145.42%
3 Year Est. Return
+584.57%
5 Year Est. Return
+927.1%
10 Year Est. Return
+12,185.37%
AUM
$3.09B
AUM Growth
+$336M
Cap. Flow
+$90M
Cap. Flow %
2.91%
Top 10 Hldgs %
28.61%
Holding
131
New
26
Increased
65
Reduced
17
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 26.41%
2 Industrials 23.96%
3 Healthcare 23.79%
4 Consumer Discretionary 11.68%
5 Financials 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXSM icon
51
Axsome Therapeutics
AXSM
$11.2B
$23.5M 0.76%
380,822
-79,473
-17% -$5.22M
GTM
52
ZoomInfo Technologies
GTM
$1.19B
$23M 0.74%
930,769
+444,884
+92% +$11.4M
GDEN
53
DELISTED
Golden Entertainment
GDEN
$22.7M 0.73%
520,856
-136,850
-21% -$5.54M
FNKO icon
54
Funko
FNKO
$338M
$21.4M 0.69%
2,272,662
+1,290,452
+131% +$13.4M
SUM
55
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$21M 0.68%
736,193
+204,145
+38% +$6.17M
NBIX icon
56
Neurocrine Biosciences
NBIX
$16.5B
$20.9M 0.68%
206,044
+6,356
+3% +$661K
ALKS icon
57
Alkermes
ALKS
$8.29B
$20.6M 0.67%
731,630
+45,688
+7% +$1.24M
BWIN
58
Baldwin Insurance Group
BWIN
$2.85B
$19.8M 0.64%
777,189
+238,882
+44% +$6.63M
ADTN icon
59
Adtran
ADTN
$626M
$19.5M 0.63%
1,229,598
-782,711
-39% -$13.6M
IIIV icon
60
i3 Verticals
IIIV
$330M
$18.6M 0.6%
759,914
+94,064
+14% +$2.47M
AMPS
61
DELISTED
Altus Power
AMPS
$17.6M 0.57%
3,216,748
+79,001
+3% +$554K
CYTK icon
62
Cytokinetics
CYTK
$10.7B
$17.1M 0.55%
486,272
+10,799
+2% +$441K
DOCN icon
63
DigitalOcean
DOCN
$14.7B
$16.9M 0.55%
+431,226
New +$13.6M
SIG icon
64
Signet Jewelers
SIG
$3.68B
$16.1M 0.52%
+207,558
New +$15.4M
ALHC icon
65
Alignment Healthcare
ALHC
$2.75B
$15.8M 0.51%
2,478,273
+301,486
+14% +$2.88M
IPAR icon
66
Interparfums
IPAR
$3.85B
$15.2M 0.49%
+107,028
New +$13.2M
COHU icon
67
Cohu
COHU
$2.47B
$14.9M 0.48%
+388,478
New +$14.1M
VRDN icon
68
Viridian Therapeutics
VRDN
$2.62B
$14.4M 0.47%
+566,498
New +$18.2M
CERE
69
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$14M 0.45%
572,876
-350,762
-38% -$10.3M
BL icon
70
BlackLine
BL
$1.66B
$11.5M 0.37%
+171,030
New +$11.8M
CERS icon
71
Cerus
CERS
$524M
$11.5M 0.37%
3,866,849
-254,002
-6% -$765K
TGTX icon
72
TG Therapeutics
TGTX
$7.64B
$11.1M 0.36%
+739,112
New +$11.2M
APLD icon
73
Applied Digital
APLD
$8.54B
$10.5M 0.34%
4,671,783
+1,078,255
+30% +$2.69M
LLAP
74
DELISTED
Terran Orbital Corporation
LLAP
$10.5M 0.34%
+5,684,536
New +$11M
HRMY icon
75
Harmony Biosciences
HRMY
$2.28B
$10.2M 0.33%
313,722
+19,855
+7% +$904K

Similar funds

Hood River Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Hood River Capital Management held 131 positions worth $3.09B, up 12% from $2.75B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Hood River Capital Management's Q1 2023 filing shows 26 new, 65 increased, 17 reduced and 17 closed positions. Its largest new stake was Lucky Strike Entertainment: 2,732,960 shares worth $46.3M. The largest sale was Celsius Holdings, an estimated $84.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.

  • Hood River Capital Management's largest Q1 2023 buy was Lucky Strike Entertainment: 2,732,960 shares worth $46.3M.
  • Hood River Capital Management added most to Axcelis in Q1 2023, an estimated $27.8M increase.
  • Hood River Capital Management's biggest Q1 2023 reduction was Celsius Holdings, cutting an estimated $84.1M.
  • Hood River Capital Management fully exited Fabrinet in Q1 2023, selling an estimated $53M.
  • Hood River Capital Management's ten largest holdings make up 29% of its $3.09B portfolio in Q1 2023.
  • Hood River Capital Management opened 26 new positions and closed 17 in Q1 2023.
  • Hood River Capital Management's portfolio value rose 12% quarter-over-quarter to $3.09B.

Based on Hood River Capital Management's 13F filing for Q1 2023, filed 15 May 2023.